del prato diabetes obese metab 2015 17 581-590 - Dapagliflozin versus glipizide as addon therapy diabetes vagina stÄndig wund in patients with type Del Prato S Nauck M DuranGarcia S Maffei L Rohwedder K Theuerkauf A et al Longterm glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as addon therapy to metformin in patients with type 2 diabetes 4year data Diabetes Obes Metab 2015176581590 doi 101111dom12459 Google Scholar 40 Longterm glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as addon therapy to metformin in patients with type 2 diabetes 4year data Longterm effects of dapagliflozin plus saxagliptin versus glimepiride Corresponding Author S Del Prato Department of Clinical and Experimental Medicine University of Pisa Pisa Italy Correspondence to Stefano Del Prato MD PhD Section of Diabetes Department of Clinical and Experimental Medicine Ospedale Cisanello Via Paradisa 2 56124 Pisa Italy Email email protected Search for more papers by this author Efficacy and safety of dapagliflozin a sodium glucose cotransporter 2 Longterm glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as addon therapy to metformin in patients with type 2 diabetes 4year data Del Prato S Nauck M DuránGarcia S Maffei L Rohwedder K Theuerkauf A Parikh S Diabetes Obes Metab 176581590 06 Apr 2015 Longterm glycaemic response and tolerability of Europe PMC Diabetes Obes Metab 2015 Jun176581590 doi 101111dom12459 S Del Prato 1 M Nauck 2 S DuránGarcia 3 L Maffei 4 K Rohwedder 5 A Theuerkauf 6 S Parikh 7 Affiliations 1 Department of Clinical and Experimental Medicine University of Pisa Pisa Italy 2 Diabetes Longterm glycaemic response and tolerability of dapagliflozin versus a Del Prato at risk for type 2 diabetes S 0000000253880270 Diabetes Obesity Metabolism 06 Diabetes Obes Metab 171110751084 04 Sep 2015 Cited by 40 articles PMID 26212528 Dapagliflozin a review of its use in type 2 diabetes mellitus Plosker GL Drugs 72 Durability of glycaemic efficacy over 2 years with dapagliflozin versus Emerging Role of SGLT2 Inhibitors for the Treatment of Obesity Longterm glycaemic response and tolerability of dapagliflozin versus a Del Prato S Nauck M DuránGarcia S et al Longterm glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as addon therapy to metformin in patients with type 2 diabetes 4year data Diabetes Obes Metab 2015 17 6581590 Google Scholar Diabetes Obesity and Metabolism Del Prato S Nauck M DuránGarcia S Maffei L Rohwedder K Theuerkauf A Parikh S Longterm glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as addon therapy to metformin in patients with type 2 diabetes 4year data Diabetes Obes Metab 201517581590 doi 101111dom12459 Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Longterm glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as addon therapy to metformin in patients with type 2 diabetes 4year data Del Prato S Nauck M DuránGarcia S Maffei L Rohwedder K Theuerkauf A Parikh S Diabetes Obes Metab 176581590 06 Apr 2015 Del Prato S Nauck M DuranGarcia S Maffei L Rohwedder K Theuerkauf A et al Longterm glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as addon therapy to metformin in patients with type 2 diabetes 4year data Diabetes Obes Metab 201517581590 doi 101111dom12459 Google gestational diabetes carbs per day Scholar 57 Matthaei S
biskuit buat orang diabetes
buku tentang diabetes